Table 1.
Clinical characteristics of SCLC patients.
| Parameters | Clinical values∗ | Stage I | Stages II + III | P value∗∗ |
|---|---|---|---|---|
| Age (years old) | 65 (49, 81) | 67 (51, 81) | 63 (49, 81) | 0.2506 |
| Sex (male/female) | 24/8 | 12/4 | 12/4 | 0.9999 |
| CYFRA21-1 (ng/ml) | 4.94 (1.24, 19.53) | 3.41 (1.24, 19.53) | 3.07 (2.04, 4.43) | 0.5033 |
| CEA (ng/ml) | 4.33 (0.83, 18.37) | 2.97 (0.83, 16.59) | 2.52 (1.37, 18.37) | 0.9786 |
| NSE (ng/ml) | 14.37 (1.83, 34.00) | 10.74 (1.83, 20.26) | 15.60 (11.38, 34.00) | 7.56 × 10–4 |
| SCCA (ng/ml) | 0.97 (0.20, 3.08) | 0.88 (0.20, 1.83) | 0.86 (0.21, 3.08) | 0.9742 |
∗Reported are median and range, except for sex is total individuals. ∗∗P values for age, CYFRA21-1, CEA, NSE, and SCCA were generated by Wilcoxon rank sum test; P value for sex was generated by Fisher's exact test.